| Product Code: ETC9965882 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Fibromyalgia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Fibromyalgia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Fibromyalgia Market - Industry Life Cycle |
3.4 United States (US) Fibromyalgia Market - Porter's Five Forces |
3.5 United States (US) Fibromyalgia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Fibromyalgia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Fibromyalgia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Fibromyalgia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Fibromyalgia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Fibromyalgia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of fibromyalgia in the US |
4.2.2 Growing aging population leading to higher prevalence of fibromyalgia |
4.2.3 Advancements in medical research and technology improving treatment options for fibromyalgia patients |
4.3 Market Restraints |
4.3.1 Lack of definitive diagnostic tests for fibromyalgia leading to misdiagnosis |
4.3.2 Limited understanding of the exact cause of fibromyalgia hindering development of targeted therapies |
4.3.3 High cost of treatment for fibromyalgia patients impacting accessibility to care |
5 United States (US) Fibromyalgia Market Trends |
6 United States (US) Fibromyalgia Market, By Types |
6.1 United States (US) Fibromyalgia Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Fibromyalgia Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Fibromyalgia Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Fibromyalgia Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Fibromyalgia Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Fibromyalgia Market Revenues & Volume, By Therapy, 2021- 2031F |
6.2.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Fibromyalgia Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Fibromyalgia Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Fibromyalgia Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Fibromyalgia Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Fibromyalgia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Fibromyalgia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Fibromyalgia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Fibromyalgia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Fibromyalgia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Fibromyalgia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Fibromyalgia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Fibromyalgia Market Import-Export Trade Statistics |
7.1 United States (US) Fibromyalgia Market Export to Major Countries |
7.2 United States (US) Fibromyalgia Market Imports from Major Countries |
8 United States (US) Fibromyalgia Market Key Performance Indicators |
8.1 Average time taken for diagnosis of fibromyalgia |
8.2 Percentage of fibromyalgia patients using alternative therapies |
8.3 Number of clinical trials focusing on fibromyalgia treatments |
9 United States (US) Fibromyalgia Market - Opportunity Assessment |
9.1 United States (US) Fibromyalgia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Fibromyalgia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Fibromyalgia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Fibromyalgia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Fibromyalgia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Fibromyalgia Market - Competitive Landscape |
10.1 United States (US) Fibromyalgia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Fibromyalgia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here